tiprankstipranks
Trending News
More News >
Welcia Holdings Co., Ltd. (JP:3141)
:3141
Japanese Market
Advertisement

Welcia Holdings Co., Ltd. (3141) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3141

Welcia Holdings Co., Ltd.

(3141)

Rating:72Outperform
Price Target:
¥3,212.00
▲(11.18% Upside)
Welcia Holdings' strong financial performance, characterized by robust revenue growth and stable financial health, is the primary driver of its stock score. The technical analysis indicates a strong upward trend, though the stock is currently overbought. Valuation concerns due to a high P/E ratio slightly offset these positives.

Welcia Holdings Co., Ltd. (3141) vs. iShares MSCI Japan ETF (EWJ)

Welcia Holdings Co., Ltd. Business Overview & Revenue Model

Company DescriptionWelcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores primarily sell OTC, healthcare/nursing care, baby, and health food products, as well as dispensing, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services. In addition, it rents and sells welfare equipment; and provides housing services for elderly people. As of February 28, 2022, the company operated 2,468 stores. Welcia Holdings Co., Ltd. was incorporated in 2008 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
How the Company Makes MoneyWelcia Holdings Co., Ltd. generates revenue primarily through the sale of pharmaceuticals and health-related products in its extensive network of drugstores across Japan. The company capitalizes on a diverse product range, including over-the-counter and prescription medications, cosmetics, and everyday consumer goods. Key revenue streams include retail sales from its physical store locations and, increasingly, from its online platforms. Additionally, Welcia benefits from strategic partnerships with healthcare providers and suppliers, which help to enhance its product offerings and service quality, driving customer loyalty and repeat business.

Welcia Holdings Co., Ltd. Financial Statement Overview

Summary
Welcia Holdings exhibits strong revenue growth and maintains healthy margins despite a decline in net income. The balance sheet is stable with controlled leverage, and the company demonstrates strong cash flow generation capabilities. While there are challenges in profitability and cash flow growth, the overall financial health is robust.
Income Statement
83
Very Positive
Welcia Holdings demonstrated a consistent increase in total revenue over the past years, with a notable revenue growth rate of 5.57% from 2024 to 2025. Despite the decline in net income, the company maintained a healthy gross profit margin of 28.36% and an EBITDA margin of 4.15% in 2025. However, the net profit margin decreased to 1.16%, indicating pressure on profitability despite revenue growth.
Balance Sheet
78
Positive
The company's balance sheet reflects a stable equity position with a debt-to-equity ratio of 0.33 in 2025, showcasing controlled leverage. The equity ratio stands at 42.87%, indicating a solid financial structure. Return on Equity (ROE) was 6.02%, reflecting a decline but still signifying profitability. Overall, the balance sheet is robust with moderate risk from debt.
Cash Flow
80
Positive
Welcia Holdings reported a positive free cash flow to net income ratio of 2.49, indicating strong cash generation relative to net income. The operating cash flow to net income ratio was 3.20, showcasing efficient operations. However, the free cash flow growth rate saw a decline, suggesting potential challenges in maintaining cash flow stability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.29T1.29T1.22T1.14T1.03T949.65B
Gross Profit381.86B364.42B370.11B349.25B320.94B296.05B
EBITDA51.77B53.31B65.45B68.86B61.98B58.71B
Net Income14.96B14.96B26.45B27.03B26.45B28.00B
Balance Sheet
Total Assets579.99B579.99B551.86B537.36B463.05B435.69B
Cash, Cash Equivalents and Short-Term Investments35.01B35.01B30.53B32.85B23.40B51.92B
Total Debt81.25B81.25B82.70B86.07B62.51B47.55B
Total Liabilities325.50B325.50B307.50B304.98B255.16B255.34B
Stockholders Equity248.62B248.62B237.71B225.91B201.78B179.72B
Cash Flow
Free Cash Flow-29.23B37.23B28.17B40.49B-3.92B31.93B
Operating Cash Flow-23.59B47.84B46.53B60.30B16.23B46.40B
Investing Cash Flow-18.75B-22.74B-22.03B-36.07B-37.09B-16.15B
Financing Cash Flow-5.47B-20.77B-26.81B-14.85B-7.28B-16.97B

Welcia Holdings Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2889.00
Price Trends
50DMA
2588.96
Positive
100DMA
2543.41
Positive
200DMA
2310.82
Positive
Market Momentum
MACD
62.48
Negative
RSI
76.07
Negative
STOCH
85.07
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3141, the sentiment is Positive. The current price of 2889 is above the 20-day moving average (MA) of 2637.45, above the 50-day MA of 2588.96, and above the 200-day MA of 2310.82, indicating a bullish trend. The MACD of 62.48 indicates Negative momentum. The RSI at 76.07 is Negative, neither overbought nor oversold. The STOCH value of 85.07 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3141.

Welcia Holdings Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥599.22B32.64
1.25%7.43%-24.81%
51
Neutral
$7.95B-0.40-41.67%2.21%22.29%-1.85%
$3.68B17.4312.18%2.81%
$4.81B16.4816.26%1.43%
$4.20B18.714.93%3.39%
78
Outperform
¥217.47B14.17
1.98%8.23%12.71%
64
Neutral
¥407.77B22.12
0.35%14.79%35.84%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3141
Welcia Holdings Co., Ltd.
2,889.00
949.23
48.94%
SDGCF
Sundrug Co
31.30
2.51
8.72%
SGIPF
Sugi Holdings Co
25.32
7.56
42.57%
TSUSF
TSURUHA Holdings
11.00
-0.75
-6.38%
JP:3148
Create SD Holdings Co., Ltd.
3,440.00
365.60
11.89%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,959.00
611.84
18.28%

Welcia Holdings Co., Ltd. Corporate Events

Welcia Holdings Updates Financial Reporting for Q1 FY2026
Jul 22, 2025

Welcia Holdings Co., Ltd. announced corrections to its Financial Results Briefing and Supplementary Materials for the first quarter of the fiscal year ending February 2026. The corrections pertain to the number of employees and sales per unit, reflecting the company’s commitment to transparency and accuracy in its financial reporting.

The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1950.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.

Welcia Holdings Reports Q1 FY2026 Financial Results
Jul 8, 2025

Welcia Holdings Co., Ltd. has released its financial results for the first quarter of the fiscal year ending February 2026. The company has outlined its achievements, initiatives, and financial performance, including sales growth and store operations. The announcement reflects Welcia’s strategic focus on expanding its market presence and enhancing its service offerings, which could impact its industry positioning and stakeholder interests.

The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1950.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.

Welcia Holdings Reports Strong Q1 2025 Results Amid Upcoming Merger
Jul 8, 2025

Welcia Holdings Co., Ltd. reported a significant increase in its financial performance for the three months ending May 31, 2025, with net sales rising by 9.7% and net income attributable to owners of the parent increasing by 116% compared to the previous year. The company plans to integrate its operations with TSURUHA Holdings Inc. and will be delisted on November 27, 2025, which could have significant implications for its market positioning and stakeholders.

The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1950.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.

Welcia Holdings Expands Business Scope with Articles Amendment
Jun 25, 2025

Welcia Holdings Co., Ltd. announced a proposal to amend its Articles of Incorporation to accommodate the diversification of its business activities. The amendments include expanding its business purposes to cover welfare services for persons with disabilities, in-home nursing, health guidance, and transportation services, reflecting the company’s strategic shift towards broader healthcare and support services.

The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1800.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.

Welcia Holdings Affirms Independence Amid AEON’s Control
May 28, 2025

Welcia Holdings Co., Ltd. announced details regarding its controlling shareholder, AEON Co., Ltd., which owns a significant portion of its voting rights. Despite this, Welcia maintains operational independence and emphasizes protecting the interests of its shareholders by appointing a majority of independent directors. The company has outlined its transactions with AEON, including consumption deposits and royalty payments, ensuring terms are fairly determined.

The most recent analyst rating on (JP:3141) stock is a Hold with a Yen1950.00 price target. To see the full list of analyst forecasts on Welcia Holdings Co., Ltd. stock, see the JP:3141 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 04, 2025